HOME >> BIOLOGY >> NEWS
Antibiotic identified as potential anti-cancer candidate

A molecular mechanism that was formerly thought to be important only in bacteria has now been shown to be a potential target for an anticancer therapy based on antibiotic use. David Scheinberg and colleagues, at the Sloan-Kettering Institute, have been investigating an enzyme in humans that is similar to one in bacteria called peptide deformylase (Pdf) and have found that an antibiotic called actinonin, which inhibits the human Pdf, also inhibits tumor growth. Pdf was thought to be important only to bacteria and the bacterially-related organelles of cells of higher organisms. Pdf is an enzyme that, during protein production, removes a modification called an N-formyl group from the first amino acid, a methionine, in the protein chain. While work began on the development of antibiotics against what was thought to be a bacterial-exclusive enzyme, genome-based data searches identified several classes of Pdf-like sequences in parasites, plants and mammals. Subsequent studies showed that the Pdfs were active both in culture and in the living organism, thus potentially derailing the usefulness of these antibiotics for specifically combating infectious agents. In previous studies, Scheinberg and colleagues had found that actinonin had an antiproliferative effect on human cancer cell lines and on tumor growth in a mouse model. They theorized this growth inhibitory activity might be related to actinonin's inhibition of human Pdf. The researchers now provide the evidence to support this theory. They show that human Pdf is active in the mitochondria and is essential for cellular growth and proliferation. They have designed and created a class of new actinonin-based Pdf inhibitors, and have demonstrated that they selectively inhibit growth in several human tumor cell lines. They further demonstrate that human tumor growth in mice can be suppressed by these Pdf inhibitors and suggest a mechanism of actinonin action. Taken together, these data have significant implicat
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Oct-2004


Page: 1 2

Related biology news :

1. Antibiotic stress, genetic response and altered permeability of E. coli
2. Antibiotic treats lymphoma of the eye
3. Antibiotic inhibits cancer gene activity
4. Antibiotic resistance markers in GM plants not a risk to human health
5. Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
6. Antibiotics help combat dangerous tropical disease
7. Antibiotic resistant bacterium uses Sonar-like strategy to see enemies or prey
8. Antibiotic-resistant bacteria increased after clindamycin use for common vaginal infection
9. Link identified between Alzheimers disease and glaucoma
10. Gene identified for Crohns disease in children
11. New gene mutation identified in common type of dementia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... August 15, 2019 , ... Deep Science Ventures (DSV), a new ... a new unit dedicated to building 100 companies over the next 10 years to ... chains. , Deep Science Ventures was founded to create a better method for ...
(Date:8/14/2019)... ... August 14, 2019 , ... Carterra® Inc., the ... opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European ... The Munich CEC will be a place for researchers throughout Europe to gain ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... of Molecular Pathology, Institute of Cancer Research (ICR) in a live webinar ... about the process of biomarker and companion diagnostic development including machine learning approaches ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... ... 10, 2019 , ... An upcoming episode of Advancements with ... genome sequencing analysis. Check your local listings for more information. , Advancements will ... Consulting and will explore its revolutionary pathogenic DNA analysis technology, which predicts in ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson recently gave a ... best to characterize 3D cell culture models. The inherent problem of characterizing 3D cell ... opaque to image through and therefore traditional wide-field or even confocal microscopy only tells ...
(Date:9/8/2019)... ... 05, 2019 , ... Spartan Bioscience, the leader in on-demand ... Shopify, has been named Chief Financial Officer. , Spartan has also named ... advisors. Additionally, Spartan has hired Steve Edgett as Executive Vice President to lead ...
(Date:9/2/2019)... and LIÉGE, Belgium (PRWEB) , ... September 02, ... ... solutions for epigenetics research and in vitro diagnostics, has launched the industry’s first ... uncover the underlying biological meaning of epigenetic data and other data types. , ...
Breaking Biology Technology:
Cached News: